Literature DB >> 33326126

Blueprint for cancer research: Critical gaps and opportunities.

Lynne W Elmore1, Susanna F Greer1, Elvan C Daniels1, Charles C Saxe1, Michael H Melner1, Ginger M Krawiec1, William G Cance1, William C Phelps1.   

Abstract

We are experiencing a revolution in cancer. Advances in screening, targeted and immune therapies, big data, computational methodologies, and significant new knowledge of cancer biology are transforming the ways in which we prevent, detect, diagnose, treat, and survive cancer. These advances are enabling durable progress in the goal to achieve personalized cancer care. Despite these gains, more work is needed to develop better tools and strategies to limit cancer as a major health concern. One persistent gap is the inconsistent coordination among researchers and caregivers to implement evidence-based programs that rely on a fuller understanding of the molecular, cellular, and systems biology mechanisms underpinning different types of cancer. Here, the authors integrate conversations with over 90 leading cancer experts to highlight current challenges, encourage a robust and diverse national research portfolio, and capture timely opportunities to advance evidence-based approaches for all patients with cancer and for all communities.
© 2020 American Cancer Society.

Entities:  

Keywords:  cancer modeling; cancer screening; cancer treatment; precision medicine

Year:  2020        PMID: 33326126     DOI: 10.3322/caac.21652

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  10 in total

1.  Spirituality and financial toxicity among Hispanic breast cancer survivors in New Jersey.

Authors:  Susana Echeverri-Herrera; Molly A Nowels; Bo Qin; Irina B Grafova; Nur Zeinomar; Dhanya Chanumolu; Paul R Duberstein; Elisa V Bandera
Journal:  Support Care Cancer       Date:  2022-10-07       Impact factor: 3.359

2.  miR-499a inhibits the proliferation and apoptosis of prostate cancer via targeting UBE2V2.

Authors:  Yougan Chen; Fanghao Sun; Liansheng Zhang; Jian Zhou; Jianquan Hou
Journal:  World J Surg Oncol       Date:  2021-08-24       Impact factor: 2.754

Review 3.  Serological assessment of collagen fragments and tumor fibrosis may guide immune checkpoint inhibitor therapy.

Authors:  Christina Jensen; Neel I Nissen; Claus S Von Arenstorff; Morten A Karsdal; Nicholas Willumsen
Journal:  J Exp Clin Cancer Res       Date:  2021-10-16

Review 4.  Advances in and the Applicability of Machine Learning-Based Screening and Early Detection Approaches for Cancer: A Primer.

Authors:  Leo Benning; Andreas Peintner; Lukas Peintner
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

5.  Exosomes from M1-polarized macrophages promote apoptosis in lung adenocarcinoma via the miR-181a-5p/ETS1/STK16 axis.

Authors:  Xuan Wang; Renhong Huang; Zhouyi Lu; Zheng Wang; Xiaofeng Chen; Dayu Huang
Journal:  Cancer Sci       Date:  2022-01-28       Impact factor: 6.716

Review 6.  Clinicopathological Significance and Prognostic Values of Long Noncoding RNA BCYRN1 in Cancer Patients: A Meta-Analysis and Bioinformatics Analysis.

Authors:  Xiaoyong Han; Yongfeng Wang; Rangyin Zhao; Guangming Zhang; Chenhui Qin; Liangyin Fu; Haojie Jin; Xianglai Jiang; Kehu Yang; Hui Cai
Journal:  J Oncol       Date:  2022-07-14       Impact factor: 4.501

7.  Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma.

Authors:  Jiahao Zhu; Yutian Zhao; Gang Wu; Xiaojun Zhang; Qingqing Chen; Bo Yang; Xinwei Guo; Shengjun Ji; Ke Gu
Journal:  Oxid Med Cell Longev       Date:  2022-07-16       Impact factor: 7.310

8.  Amine oxidase, copper containing 3 exerts anti‑mesenchymal transformation and enhances CD4+ T‑cell recruitment to prolong survival in lung cancer.

Authors:  Chao-Yuan Chang; Kuan-Li Wu; Yung-Yun Chang; Pei-Hsun Tsai; Jen-Yu Hung; Wei-An Chang; Shu-Fang Jian; Yung-Chi Huang; Inn-Wen Chong; Ying-Ming Tsai; Ya-Ling Hsu
Journal:  Oncol Rep       Date:  2021-07-28       Impact factor: 3.906

9.  Comprehensive Analysis of the Effects of Genetic Ancestry and Genetic Characteristics on the Clinical Evolution of Oral Squamous Cell Carcinoma.

Authors:  Junfeng Guo; Xiaoping Liu; Yi Zeng; Taotao Liang; Kanglai Tang; Junfeng Guo; Weiwei Zheng
Journal:  Front Cell Dev Biol       Date:  2021-12-07

Review 10.  Renal Cell Cancer and Obesity.

Authors:  Anna Gluba-Brzózka; Jacek Rysz; Janusz Ławiński; Beata Franczyk
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.